Approval · Notice of Compliance 21238 · 2018
BUSCOPAN: Notice of Compliance 21238
Issued August 24, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21238
- Date
- August 24, 2018
- Company
- Sanofi Aventis
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change the approved formulation to the global sugar-coated formulation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSCOPAN | Not yet assigned | — |
Medicinal ingredients
- HYOSCINE BUTYLBROMIDE 10 MG per TAB